Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Vismodegib in Patients With Relapsed/Refractory Acute Myelogenous Leukemia and Relapsed Refractory High-Risk Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
- Status
- COMPLETED
- Phase
- PHASE1
Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML
- Status
- TERMINATED
- Phase
- PHASE1
Sulindac for Patients With AML
- Status
- WITHDRAWN
- Phase
- PHASE2
High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- NA
Brentuximab Vedotin + Re-induction Chemotherapy for AML
- Status
- COMPLETED
- Phase
- PHASE1
Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Alisertib for Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1